Jon Congleton
Chief Executive Officer, Alpine Immune Sciences.
Companies
- Avalyn Pharma Inc.Board member Apr 29, 2026 to now1
- IMMUNIC, INC.Board member Mar 31, 2026 to now2
- Mineralys Therapeutics, Inc.Board member Feb 9, 2023 to now3
- Mineralys Therapeutics, Inc.Chief executive officer Feb 9, 2023 to now3
- Alpine Immune SciencesBoard member Jun 16, 2015 to Sep 14, 20164
- Alpine Immune SciencesChief executive officer Jun 16, 2015 to Sep 14, 20164
- Alpine Immune SciencesPresident Jun 16, 2015 to Sep 14, 20164
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Mineralys Therapeutics, Inc. MLYS603,621 shares5$13.1M at $21.64Jul 13, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 13, 2026Sold 10,700 shares at $27.24 of Mineralys Therapeutics, Inc.5
- Jun 30, 2026Sold 17,000 shares at $26.82 of Mineralys Therapeutics, Inc.6
- Jun 30, 2026Sold 58,000 shares at $25.94 of Mineralys Therapeutics, Inc.6
- Apr 13, 2026Sold 15,730 shares at $26.83 of Mineralys Therapeutics, Inc.7
- Mar 31, 2026Sold 453 shares at $27.05 of Mineralys Therapeutics, Inc.8
- Mar 31, 2026Sold 55,183 shares at $26.54 of Mineralys Therapeutics, Inc.8
- Mar 31, 2026Sold 19,364 shares at $25.50 of Mineralys Therapeutics, Inc.8
- Feb 19, 2026Granted 140,900 shares of Mineralys Therapeutics, Inc.9
- Jan 12, 2026Sold 7,117 shares at $33.15 of Mineralys Therapeutics, Inc.10
- Jan 12, 2026Sold 9,119 shares at $32.21 of Mineralys Therapeutics, Inc.10
- Nov 21, 2025Exercised options 24,082 shares at $0.54 of Mineralys Therapeutics, Inc.11
- Nov 11, 2025Sold 32,850 shares at $46.89 of Mineralys Therapeutics, Inc.12
- Nov 11, 2025Sold 112,275 shares at $45.83 of Mineralys Therapeutics, Inc.12
- Nov 11, 2025Sold 29,207 shares at $45.20 of Mineralys Therapeutics, Inc.12
- Nov 11, 2025Sold 4,000 shares at $43.50 of Mineralys Therapeutics, Inc.12
- Nov 11, 2025Sold 8,862 shares at $42.31 of Mineralys Therapeutics, Inc.12
- Nov 11, 2025Sold 12,806 shares at $41.64 of Mineralys Therapeutics, Inc.12
- Oct 13, 2025Sold 1,552 shares at $43.03 of Mineralys Therapeutics, Inc.13
- Oct 13, 2025Sold 13,548 shares at $42.63 of Mineralys Therapeutics, Inc.13
- Jul 11, 2025Sold 15,884 shares at $14.51 of Mineralys Therapeutics, Inc.14
- Apr 11, 2025Sold 15,319 shares at $12.19 of Mineralys Therapeutics, Inc.15
- Jan 13, 2025Sold 18,333 shares at $9.06 of Mineralys Therapeutics, Inc.16
- Oct 11, 2024Sold 15,271 shares at $13.52 of Mineralys Therapeutics, Inc.17
- Jul 11, 2024Sold 15,746 shares at $13.34 of Mineralys Therapeutics, Inc.18
- Jun 20, 2024Sold 14,940 shares at $11.73 of Mineralys Therapeutics, Inc.19
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAvalyn Pharma Inc., Board member
- 2SEC EDGARIMMUNIC, INC., Board member
- 3
- 4SEC EDGARAlpine Immune Sciences, Board member
- 5
- 6SEC EDGARForm 4 filed Jun 30, 2026
- 7SEC EDGARForm 4 filed Apr 15, 2026
- 8SEC EDGARForm 4 filed Apr 2, 2026
- 9SEC EDGARForm 4 filed Feb 20, 2026
- 10SEC EDGARForm 4 filed Jan 13, 2026
- 11SEC EDGARForm 4 filed Nov 24, 2025
- 12SEC EDGARForm 4 filed Nov 13, 2025
- 13SEC EDGARForm 4 filed Oct 15, 2025
- 14SEC EDGARForm 4 filed Jul 15, 2025
- 15SEC EDGARForm 4 filed Apr 15, 2025
- 16SEC EDGARForm 4 filed Jan 15, 2025
- 17SEC EDGARForm 4 filed Oct 15, 2024
- 18SEC EDGARForm 4 filed Jul 12, 2024
- 19SEC EDGARForm 4 filed Jun 20, 2024